Tonix制药控股 TNXP 深 沪
已收盘 10-02 16:00:00 美东时间
8.91
-0.320
-3.47%
华盛通- 最 高9.56
- 今 开9.38
- 成交量 80.30万股
- 最 低 8.69
- 昨 收 9.23
- 总市值 1.53亿
- 52周最高 20.69
- 市盈率 静 --
- 换手率 4.68%
- 52周最低 8.69
- 委 比 98.92%
- 总股本 1715.10万
- 历史最高 13440000000.00
- 量 比 2.10
- 振 幅 9.43%
- 历史最低 8.69
- 每 手 1
- 风险率 3.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic TONMYA On Oct 1; Paragraph IV Certification Challenges Four TONMYA Patents Listed In FDA Orange Book; Co Intends To Enforce TONMYA Intellectual Property Rights
On October 1, 2026, Tonix Pharmaceuticals Holding Corp. (the "Company") received a notice (the "Notice") from Dr. Reddy’s Laboratories Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, "DRL") stating that DRL filed an Abbreviated New Drug Application ("ANDA") containing a Paragraph IV patent ce...
10-03 05:32
Tonix Pharmaceuticals Announces Second Major Managed Medicare Agreement For TONMYA
Agreement for the treatment of fibromyalgia in adults that is effective immediately, adding approximately 21 million Medicare lives (38% of approximately 55 million Medicare lives in the U.S.). Medicare coverage now totals 32 million Medicare lives in the U.S. (58% of approximately 55 million Medica...
09-22 19:09
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
Tonix Pharmaceuticals announced a major expansion of Medicare coverage for TONMYA, its fibromyalgia treatment, adding approximately 21 million Medicare lives, bringing total coverage to 32 million Medicare lives (58% of the U.S. Medicare population). Overall, TONMYA now covers about 166 million U.S. lives (53% of the total U.S. population). This new agreement reflects TONMYA's value as a first-in-class, non-opioid analgesic for long-term use in a...
09-22 11:00
Tonix Pharma Appoints New Chief Commercial Officer
Tonix Pharma ( ($TNXP) ) just unveiled an announcement. On September 8, 2026, T...
09-08 19:29
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Tonix Pharmaceuticals promoted Thomas Englese to Chief Commercial Officer, recognizing his leadership in launching TONMYA® for fibromyalgia and expanding commercial operations. Englese, previously Executive Vice President, Commercial Operations, will continue to oversee sales, marketing, and market access for TONMYA and migraine treatments Zembrace® SymTouch® and Tosymra®. CEO Seth Lederman highlighted Englese's instrumental role in building the ...
09-08 11:00
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
Tonix Pharmaceuticals Holding Corp. announced that its management team, including CEO Seth Lederman, M.D., will participate in a fireside chat at Cantor’s 2026 Global Healthcare Conference on September 10, 2026, at 3:55-4:25 p.m. ET. The event will be webcast live and available for replay on the company’s website. Tonix, a biopharmaceutical company, focuses on CNS disorders, infectious diseases, immunology, and rare diseases. Its flagship product...
09-02 11:00
Tonix Pharma Rallies as Insider Bets and Pipeline Build
Tonix Pharma ( ($TNXP) ) has risen by 9.16%. Read on to learn why. Tonix Pharma...
08-29 22:02
Tonix Pharma Names CEO Seth Lederman Interim CMO
An announcement from Tonix Pharma ( ($TNXP) ) is now available. On August 18, 2...
08-19 04:36
财报速睇 | Tonix制药控股 2026财年Q2营收0.14亿美元，同比增长577.9%；归母净利润亏损0.41亿美元，同比亏损扩大43.4%
华盛资讯8月10日讯，Tonix制药控股公布2026财年Q2业绩，公司Q2营收0.14亿美元，同比增长577.9%，归母净利润亏损0.41亿美元，同比亏损扩大43.4%。
08-10 20:36
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
Tonix Pharmaceuticals Holding Corp. announced that its management team will participate in two investor conferences in August and September 2026. Seth Lederman, M.D., President and CEO, will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11 and attend 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 16. Tonix is a biotech company focused on CNS disorders, infe...
08-05 11:00
